Lin WANG, Lingjun SHEN, Haiwen LI, Xiaoyan WANG, Jianpeng GAO, Zhiqiang MA. Analysis of Nutritional Status and Immune Function of Tuberculosis Patients in Yunnan[J]. Journal of Kunming Medical University, 2023, 44(1): 109-115. doi: 10.12259/j.issn.2095-610X.S20230116
Citation: Yu Ming Li , Chen Jie , Chen Yong Gang , Luo Ji , Peng Jiang Li . An Analysis of Biochemical Characteristics of Liver Injury In Duced by Statins[J]. Journal of Kunming Medical University, 2018, 39(08): 13-17.

An Analysis of Biochemical Characteristics of Liver Injury In Duced by Statins

Funds:

基金: 昆明市卫计委基础研究基金资助项目 (2012-01-03);

  • Received Date: 2018-04-19
  • Objectives To provide theoretical basis for the clinical rational using of drugs, biochemical characteristics of the liver injuries induced by the atorvastatin, simvastatin and lovastatin were analyzed and compared by replicating the rats model of liver injuries induced by statins, Methods 80 SPF SD rats (8 weeks of age) , half male and half female, were divided into four groups randomly: control group, simvastatin group, lovastatin group, atorvastatin group. Human equivalent doses were administered to the latter three groups of rats which were sacrificed to draw blood on the 10 th, 35 th and 55 th day respectively (via the femoral artery) for testing liver function index, including total bilirubin (TBIL) , direct bilirubin (DBIL) , indirect bilirubin (IBIL) , aspartateaminotransferase (AST) , alanineaminotransferase (ALT) , alkalinephosphatase (ALP) . Results (1) The increases in TBIL, DBIL, IBIL for treatment group in comparison with control group had statistical significance (P<0.01) .2) At the 55 th day of administration, there was a significant statistical difference between the simvastatin group and the lovastatin group in AST (P<0.05) ;3) Meanwhile, there was great statistical difference between the atorvastatin group and lovastatin group in ALP (P<0.01) . Conclusion The rats in the three experimental groups suffered from minor to moderate liver injuries, most of which being cholestasis type. It is speculated that this kind of liver injuries are closely related to the obstacle of transfering bile.
  • [1]于乐成, 茅益民, 陈成伟, 等.药物性肝损伤诊治指南[J].临床肝胆病杂志, 2015, 31 (11) :1752-1769.
    [2]
    [2]CHALASANI N P, HAYASHI PH, BONKOVSKY H L, et al.ACG Clinical Guideline:the diagnosis and management of idiosyncratic drug-induced liver injury[J].Am J Gastroenterol, 2014, 109 (7) :950-966.
    [3]
    [3]HAYASHI P H, FONTANA R J.Clinical features, diagnosis, and natural history of drug-induced liver injury[J].Semin Liver Dis, 2014, 34 (2) :134-144.
    [4]
    [4]ROBLES-DIAZ M, LUCENA MI, KAPLOWITZ N, et al.Use of Hy's law and a new composite algorithm to predict acute liver failure in patients with drug-induced liver injury[J].Gastroenterology, 2014, 147 (1) :109-118.
    [5]马葵芬, 谢先吉, 刘莹, 等.细胞色素P450酶基因多态性及其介导的药物性肝损伤研究进展[J].中国药理学与毒理学杂志, 2013, 27 (5) :889-892.
    [6]曾含清, 张琼, 彭文兴, 等.阿托伐他汀致肝损伤的机制[J].药物不良反应志, 2012, 14 (4) :232-235.
    [7]刘敏惠, 陈崇泽.阿托伐他汀致11例患者肝损伤及费用分析[J].海峡药学, 2018, 30 (02) :265-268.
    [8]彭江丽, 马国伟, 喻明丽, 等.洛伐他汀联合异烟肼、利福平、吡嗪酰胺致大鼠肝损伤的实验研究[J].安徽医药, 2017, 21 (12) :2157-2163.
    [9]陈洁, 王俊龙, 马国伟, 等.抗结核药与辛伐他汀联用致肝损伤的特征及其机制研究[J].抗感染药学, 2016, 13 (04) :729-735.
    [10]罗季, 陈永刚, 喻明丽, 等.抗结核药与阿托伐他汀联用致肝损伤的特征及其机制研究[J].抗感染药学, 2016, 13 (05) :978-985.
    [11] 丁德云, 张淑芳, 马力, 等.阿托伐他汀的药物专论[M].重庆:重庆出版社, 2014:644-649.
    [12]刘志军, 熊玉卿.药代动力学/药效学模型研究进展及其在他汀类药物临床治疗的应用[J].中国临床药理学杂志, 2015, 31 (15) :1552-1554.
    [13]
    [13]BOELSTERLI U A, LIM P L.Mitochondrial abnormalitiesa link to idiosyncratic hepatotoxicity drug[J].Toxicol Appl Pharmacol, 2007, 220 (1) :92-107.
    [14]
    [14]AU J S, NAVARRO V J, ROSSI S.et al.Review article:drug-induced liver injure-its pathophysiology and evolving diagnostic tools[J].Aliment Pharmacol Ther, 2011, 34 (1) :11-20.
    [15] 范颖, 赵红, 药物性肝损伤防治指南[J], 中华全科医师杂志, 2016, 15 (6) :416-420.
  • Relative Articles

    [1] Yihan YANG, Huamei CHEN, Yu FANG, Yuxin WANG, Xi ZHAN. Mechanism of Rosiglitazone in Reducing Liver Ischemia Reperfusion Injury in Rats by Inducing HO-1. Journal of Kunming Medical University, 2024, 45(7): 14-22.  doi: 10.12259/j.issn.2095-610X.S20240703
    [2] Nihong LU, Honglu LIU, Yangjun CHEN, Yaping SUN, Yan YANG, Yongrui YANG, Jie LI. The Association between ESAT-6 Combined Multiple Detection Indicators and the Severity of Anti-tuberculosis Drug-induced Liver Injury. Journal of Kunming Medical University, 2024, 45(8): 52-57.  doi: 10.12259/j.issn.2095-610X.S20240808
    [3] Xuejiao WU, Jiangli PENG, Hao FAN, Lu WANG, Jie CHEN, Hui LIU. Clinical Features and Prognostic Factors of 310 Patients with Antituberculosis Drug-induced Liver Injury. Journal of Kunming Medical University, 2024, 45(3): 157-165.  doi: 10.12259/j.issn.2095-610X.S20240324
    [4] Nihong LU, Honglu LIU, Yangjun CHEN, Meiyan LIU, Yongrui YANG, Yingrong DU. Analysis of Characteristic Indexes of Liver Injury Model Induced by Different Antituberculosis Drugs in Mice. Journal of Kunming Medical University, 2023, 44(6): 6-13.  doi: 10.12259/j.issn.2095-610X.S20230615
    [5] Nihong LU, Honglu LIU, Jiawei XIA, Yangjun CHEN, Linjun SHEN, Yongrui YANG, Jie LI. Clinical Evaluation of Immune Function and SAA, MMP-9 and MMP-14 in Liver Injury Caused by Anti-Tuberculous Drugs. Journal of Kunming Medical University, 2022, 43(4): 50-54.  doi: 10.12259/j.issn.2095-610X.S20220410
    [6] Jing TANG, Jun-chao HUANG, Ya-fei HUANG, Ming-zhu GENG, Xiao-qin MAO, Jian-ping PU. Application of Lipoprotein-associated Phospholipase A2 in Coronary Heart Disease Patients Taking Statins. Journal of Kunming Medical University, 2021, 42(12): 6-10.  doi: 10.12259/j.issn.2095-610X.S20211205
    [7] Yan LIANG, Jian-bo GAO, Jun-yan MA, Hao YANG. Diagnostic Effect and Imaging Characteristics of High Frequency Ultrasound in Limb Skeletal Muscle Injury. Journal of Kunming Medical University, 2021, 42(10): 157-161.  doi: 10.12259/j.issn.2095-610X.S20211015
    [8] Ni-hong LU, Hong-lu LIU, Yang-jun CHEN, Yan YANG, Yong-rui YANG, Ying-rong DU. Characteristics of Infection Indexes in Patients with Antituberculous Drug-induced Liver Injury. Journal of Kunming Medical University, 2021, 42(11): 57-61.  doi: 10.12259/j.issn.2095-610X.S20211111
    [9] Jing LUO, Xian-ling GAO, Jian-lin SHAO, Chao ZHANG, Qi ZHANG. Mechanism of Biliverdin in Improving Cerebral Ischemia-reperfusion Injury in Rats. Journal of Kunming Medical University, 2020, 41(11): 1-6.  doi: 10.12259/j.issn.2095-610X.S20201107
    [10] Liu Chun Ming , Liu Yun , He Li Ping , Zhang Yang Ping , Zhao Yi Bin , Zhou Yi Qing , Cao Xuan Lan , Deng Xiao Li . Clinical Characteristics of Brainstem Auditory Evoked Potential in Children with Brain Injury Syndrome. Journal of Kunming Medical University, 2019, 40(03): 78-82.
    [11] Li Hong Yang , Su Tian Yi , Gong Jian Ping , Gan Ping , Yang Bu Rong , Cun Ying Li , Cha Yong , Zhao Gong Fang . . Journal of Kunming Medical University, 2018, 39(09): 11-14.
    [12] Meng Hong Qiong , Su Hui Peng , Long Qiong Hua , Wang Ting Ting , Hu Yang . Effect of Statins on Lower Airway Bacterial Colonization in Elderly Patients with Stable Chronic Obstructive Pulmonary Disease of Different Severity. Journal of Kunming Medical University, 2018, 39(07): 61-66.
    [13] Zhao Yi, Yan Zi Jun . A Study on the Influence of Atorvastatin for the CXCL Chemokines and Vascular Endothelial Damage Indexes of Patients with Angina Pectoris of Coronary Heart Disease. Journal of Kunming Medical University, 2018, 39(08): 59-63.
    [14] Wang Lu , Chen Jie , Kong Wei Long , Yu Ming Li . Biochemical Characteristics of Liver Injury Induced by Atorvastatin Combined HRZ. Journal of Kunming Medical University, 2018, 39(03): 42-48.
    [15] Liu Hu Jun , Gao Li Ping . . Journal of Kunming Medical University, 2017, 38(03): 94-97.
    [16] Zhang Wei . Effect of SGK1 on the Protection of Ischemia Reperfusion Model Rats. Journal of Kunming Medical University,
    [17] Li Sheng Hao . Characteristic of Liver Injury Induced by Simvastatin Combined with HRZ in SD Rats. Journal of Kunming Medical University,
    [18] Wang Wei Li . . Journal of Kunming Medical University,
    [19] Ma Jia . . Journal of Kunming Medical University,
    [20] . Protecton Mechanism of Shuanghuanglian against Liver Ischemia/Reperfusion injury in Rats. Journal of Kunming Medical University,
  • Cited by

    Periodical cited type(13)

    1. 姚蕙,麻浩,骆芙瑶,顾嘉楠,赵修南,高月求,单俊杰. 猫爪草活性多糖RTP-60-3V-Ⅲ化学结构及抗药物性肝损伤的作用. 中国新药杂志. 2024(04): 360-371 .
    2. 李智,魏栋,万梅绪,张燕欣,李智,原景,李德坤,高磊,鞠爱春. 他汀类药物致药物性肝损伤的研究进展. 药物评价研究. 2024(05): 941-950 .
    3. 黄芳. 宁德市近10年药物性肝损伤不良反应报告分析. 药物评价研究. 2024(12): 2874-2880 .
    4. 夏斐斐,宋冰雪,宋雨晴,田嘉伟,闫慧,黄玉晓,辛辉,梁惠. 高剂量阿托伐他汀对肝损伤小鼠胆汁酸代谢的影响及其机制. 精准医学杂志. 2023(05): 383-386 .
    5. 董卉,钱康. 降脂通脉汤配合西药治疗冠心病心绞痛合并高血脂症的疗效评价. 中国中医药科技. 2023(05): 987-989 .
    6. 白岩,史华山,郭瑞敏,李向红,石勇. 血浆吸附技术用于治疗高脂血症的疗效及安全性分析. 川北医学院学报. 2021(05): 592-595 .
    7. 李敏,朱浩,梅凌,刘鹏. 枳实薤白桂枝汤与他汀类药物对冠心病稳定型心绞痛合并高血脂症的二级预防作用探讨. 广州中医药大学学报. 2021(08): 1583-1587 .
    8. 付嘉玉,高顺,车艳,沈春健. 体外循环围手术期肝损伤相关危险因素的研究进展. 中国临床新医学. 2021(09): 934-937 .
    9. 蒋娅,崔鲂. 他汀类药物治疗原发肾病综合征致肝损害的临床特点分析. 中华灾害救援医学. 2020(03): 147-151 .
    10. 杨小林,张春凤,陈平,王振中,肖伟,王如锋. 竹节参皂苷及其组合物的降脂活性比较研究. 上海中医药大学学报. 2020(03): 57-61+90 .
    11. 李春姬. 他汀类药物引发乙型肝炎患者肝损伤的危险因素分析. 国际医药卫生导报. 2020(08): 1110-1111-1112 .
    12. Lukun YANG,Cuizhe LIU. Effect of Cholesterol Content in Diet on Atorvastatin (ATO)-induced Liver Injury in Golden Hamsters. Medicinal Plant. 2020(05): 59-62+67 .
    13. 严进. 阿托伐他汀钙片强化治疗时不同剂量用药对老年冠心病心力衰竭患者临床疗效及心功能的影响比较. 中国医药科学. 2019(11): 21-25 .

    Other cited types(6)

  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (2559) PDF downloads(245) Cited by(19)
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return